Published in Circ Cardiovasc Qual Outcomes on January 12, 2010
Void for vagueness: a problem in research consent? Circ Cardiovasc Qual Outcomes (2010) 0.87
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. J Am Coll Dent (2014) 22.13
Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet (2001) 6.07
(Almost) everything you ever wanted to know about informed consent. [Review of: Faden, RR and Beauchamp, TL. A history and theory of informed concsent. New York and Oxford: Oxford University Press, 1986]. Med Humanit Rev (1987) 5.53
Influence of the HIPAA Privacy Rule on health research. JAMA (2007) 5.44
Factors affecting quality of informed consent. BMJ (1993) 3.68
The dysregulation of human subjects research. JAMA (2007) 3.44
Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research. Acad Med (2003) 3.25
Standards for privacy of individually identifiable health information. Final rule. Fed Regist (2002) 2.87
Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. J Clin Oncol (2003) 2.41
Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research. Acad Med (2003) 2.36
Improvement of informed consent and the quality of consent documents. Lancet Oncol (2008) 2.21
The impact of disease severity on the informed consent process in clinical research. Am J Med (1996) 1.94
Compensation for injured research subjects. N Engl J Med (2006) 1.82
Informed consent for research and authorization under the Health Insurance Portability and Accountability Act Privacy Rule: an integrated approach. Ann Intern Med (2006) 1.73
Measuring trust in medical researchers. Med Care (2006) 1.69
Potential impact of the HIPAA privacy rule on data collection in a registry of patients with acute coronary syndrome. Arch Intern Med (2005) 1.68
Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. J Gen Intern Med (2006) 1.63
Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Acad Med (2006) 1.43
Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. Control Clin Trials (1996) 1.30
Risk perception and decision processes underlying informed consent to research participation. Soc Sci Med (2007) 1.21
Compensation for research-related injuries. Ethical and legal issues. J Leg Med (2006) 1.19
Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. J Law Med Ethics (2006) 1.19
Compensating injured research subjects: I. The moral argument. Hastings Cent Rep (1976) 1.05
Developing model language for disclosing financial interests to potential clinical research participants. IRB (2007) 1.03
Who refuses enrollment in cardiac clinical trials? Clin Trials (2007) 0.96
Effects of disclosing financial interests on participation in medical research: a randomized vignette trial. Am Heart J (2008) 0.90
Assessment of medical school institutional review board policies regarding compensation of subjects for research-related injury. Am J Med (2005) 0.88
Paying for research related injuries in the US. BMJ (2006) 0.88
Local perspective of the impact of the HIPAA privacy rule on research. Cancer (2006) 0.87
Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants. Clin Trials (2007) 0.86
Compensation for research injuries. IRB (2005) 0.83
Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68
The limitations of "vulnerability" as a protection for human research participants. Am J Bioeth (2004) 14.06
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst (2005) 13.00
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature (2012) 8.03
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Patients' views on identifiability of samples and informed consent for genetic research. Am J Bioeth (2008) 5.73
Dealing with the long-term social implications of research. Am J Bioeth (2011) 5.41
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Ethics and best practice guidelines for training experiences in global health. Am J Trop Med Hyg (2010) 5.05
Medical and nursing students' television viewing habits: potential implications for bioethics. Am J Bioeth (2008) 4.94
Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell (2011) 4.54
Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol (2010) 4.50
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med (2002) 4.42
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 3.96
Measuring patients' trust in physicians when assessing quality of care. Health Aff (Millwood) (2004) 3.92
Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med (2009) 3.85
Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79
MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol (2009) 3.72
Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med (2004) 3.64
Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med (2004) 3.58
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Ethical goals of community consultation in research. Am J Public Health (2005) 3.46
Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting. Hepatology (2014) 3.40
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J (2007) 3.34
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation (2009) 3.18
Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol (2010) 3.16
Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell (2013) 3.13
The cost of institutional review boards in academic medical centers. N Engl J Med (2005) 3.06
Bioethics consultation in the private sector. Hastings Cent Rep (2002) 3.01
Cost of cancer care: issues and implications. J Clin Oncol (2007) 3.00
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA (2008) 2.96
Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database. Ann Surg (2004) 2.95
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med (2013) 2.86
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Variants modulating the expression of a chromosome domain encompassing PLAG1 influence bovine stature. Nat Genet (2011) 2.81
Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA (2007) 2.75
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol (2012) 2.72
The inescapable relevance of bioethics for the practicing clinician. Chest (2006) 2.70
Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA (2010) 2.68
Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med (2008) 2.65
The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science (2014) 2.63
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol (2009) 2.58
Protecting research subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community. Ann Emerg Med (2003) 2.56
Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol (2008) 2.55
Ethical considerations for short-term experiences by trainees in global health. JAMA (2008) 2.48
Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet (2009) 2.40
Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood (2004) 2.30
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. Arch Intern Med (2010) 2.28
Economic return of clinical trials performed under the pediatric exclusivity program. JAMA (2007) 2.28
Relationship between patient satisfaction with inpatient care and hospital readmission within 30 days. Am J Manag Care (2011) 2.27
Clinical predictors of major infections after cardiac surgery. Circulation (2005) 2.27
Perceived discrimination and reported delay of pharmacy prescriptions and medical tests. J Gen Intern Med (2005) 2.25
Changing gender prevalence of stone disease. J Urol (2007) 2.25
Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res (2005) 2.18
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol (2009) 2.14
Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res (2006) 2.14
Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol (2010) 2.12
Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation (2009) 2.11
Geographic variation in carotid revascularization among Medicare beneficiaries, 2003-2006. Arch Intern Med (2010) 2.08
Assessment of temporal trends in mortality with implementation of a statewide ST-segment elevation myocardial infarction (STEMI) regionalization program. Ann Emerg Med (2011) 2.03
Urinary diversion in patients with spinal cord injury in the United States. Urology (2012) 2.03
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer. Cancer Res (2009) 2.01
The Presidential Bioethics Commission's database of human subjects research. IRB (2013) 1.98
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure. Circ Heart Fail (2009) 1.95
Promoting quality: the health-care organization from a management perspective. Int J Qual Health Care (2007) 1.94
Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings? Clin Infect Dis (2013) 1.92
Development of a scale to measure patients' trust in health insurers. Health Serv Res (2002) 1.91
Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2010) 1.88
MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem (2011) 1.88
Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med (2008) 1.88
The effect of suit wear during an intensive therapy program in children with cerebral palsy. Pediatr Phys Ther (2011) 1.86
Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis. Arthritis Rheum (2003) 1.86
Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer. J Urol (2004) 1.85
The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer (2010) 1.84
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Trust and satisfaction with physicians, insurers, and the medical profession. Med Care (2003) 1.77
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood (2010) 1.76
Medicine. A portfolio model of drug development for tuberculosis. Science (2006) 1.75
Regulatory and ethical considerations for linking clinical and administrative databases. Am Heart J (2009) 1.75
Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs. Health Aff (Millwood) (2008) 1.74
Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol (2008) 1.72
Metaanalysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J (2005) 1.71
Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology (2008) 1.71
Ethics in human subjects research: do incentives matter? J Med Philos (2004) 1.70
Reducing the costs of phase III cardiovascular clinical trials. Am Heart J (2005) 1.69
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol (2005) 1.69
Measuring trust in medical researchers. Med Care (2006) 1.69